Clinical Trials Browser

Phase 1 × 3,3'-diindolylmethane × Clear all

NCT00450229 2015-12-04

Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT01022333 2009-12-01

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Phase 1 Unknown

Breast Neoplasms